Cargando…
Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature
Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which do not specify or discuss the use of inferior vena cava filters in malignancy. Adherence to these guidelines is known to be variable. We aimed...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797600/ https://www.ncbi.nlm.nih.gov/pubmed/33456754 http://dx.doi.org/10.1177/2045894020953841 |
_version_ | 1783634903751983104 |
---|---|
author | Craven, Philip Daly, Ciara Sikotra, Nisha Clay, Tim Gabbay, Eli |
author_facet | Craven, Philip Daly, Ciara Sikotra, Nisha Clay, Tim Gabbay, Eli |
author_sort | Craven, Philip |
collection | PubMed |
description | Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which do not specify or discuss the use of inferior vena cava filters in malignancy. Adherence to these guidelines is known to be variable. We aimed to see if there was consistent management of venous thromboembolism among Medical Oncologists/Haematologists and Respiratory Physicians, with respect to inferior vena cava filter use in the setting of suspected and confirmed malignancy. Medical Oncologists, Haematologists and Respiratory Physicians were surveyed with four theoretical cases. Case 1 concerns a patient who develops a pulmonary embolism following spinal surgery. Cases 2 and 4 explore the use of inferior vena cava filters in the setting of malignancy. Case 3 covers the role of inferior vena cava filters in recurrent thrombosis despite systemic anticoagulation. There were 56 responses, 32 (57%) Respiratory Physicians and 24 (43%) Haematologists/Oncologists. Respiratory Physicians were significantly more likely to insert an inferior vena cava filter in case 1 (p = 0.04) whilst Haematologists/Medical Oncologists were more likely to insert an inferior vena cava filter in case 3 (p = 0.03). No significant differences were found in cases 2 and 4. There were significant disparities in terms of type and timing of anticoagulation. Consistency of recommendations with guidelines was variable likely in part because guidelines are themselves inconsistent. The heterogeneity in responses highlights the variations in venous thromboembolism management, especially in Cancer Associated Thrombosis. International Societies should consider addressing inferior vena cava filter use specifically in the setting of Cancer Associated Thrombosis. Collaboration between interested specialities would assist in developing consistent, evidence-based guidelines for the use of inferior vena cava filters in the management of venous thromboembolism. |
format | Online Article Text |
id | pubmed-7797600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77976002021-01-15 Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature Craven, Philip Daly, Ciara Sikotra, Nisha Clay, Tim Gabbay, Eli Pulm Circ Research Article Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which do not specify or discuss the use of inferior vena cava filters in malignancy. Adherence to these guidelines is known to be variable. We aimed to see if there was consistent management of venous thromboembolism among Medical Oncologists/Haematologists and Respiratory Physicians, with respect to inferior vena cava filter use in the setting of suspected and confirmed malignancy. Medical Oncologists, Haematologists and Respiratory Physicians were surveyed with four theoretical cases. Case 1 concerns a patient who develops a pulmonary embolism following spinal surgery. Cases 2 and 4 explore the use of inferior vena cava filters in the setting of malignancy. Case 3 covers the role of inferior vena cava filters in recurrent thrombosis despite systemic anticoagulation. There were 56 responses, 32 (57%) Respiratory Physicians and 24 (43%) Haematologists/Oncologists. Respiratory Physicians were significantly more likely to insert an inferior vena cava filter in case 1 (p = 0.04) whilst Haematologists/Medical Oncologists were more likely to insert an inferior vena cava filter in case 3 (p = 0.03). No significant differences were found in cases 2 and 4. There were significant disparities in terms of type and timing of anticoagulation. Consistency of recommendations with guidelines was variable likely in part because guidelines are themselves inconsistent. The heterogeneity in responses highlights the variations in venous thromboembolism management, especially in Cancer Associated Thrombosis. International Societies should consider addressing inferior vena cava filter use specifically in the setting of Cancer Associated Thrombosis. Collaboration between interested specialities would assist in developing consistent, evidence-based guidelines for the use of inferior vena cava filters in the management of venous thromboembolism. SAGE Publications 2021-01-07 /pmc/articles/PMC7797600/ /pubmed/33456754 http://dx.doi.org/10.1177/2045894020953841 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Article Craven, Philip Daly, Ciara Sikotra, Nisha Clay, Tim Gabbay, Eli Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature |
title | Dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical
Oncologists and a review of the literature |
title_full | Dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical
Oncologists and a review of the literature |
title_fullStr | Dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical
Oncologists and a review of the literature |
title_full_unstemmed | Dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical
Oncologists and a review of the literature |
title_short | Dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical
Oncologists and a review of the literature |
title_sort | dilemmas in anticoagulation and use of inferior vena cava filters in venous
thromboembolism; a survey of respiratory physicians, haematologists and medical
oncologists and a review of the literature |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797600/ https://www.ncbi.nlm.nih.gov/pubmed/33456754 http://dx.doi.org/10.1177/2045894020953841 |
work_keys_str_mv | AT cravenphilip dilemmasinanticoagulationanduseofinferiorvenacavafiltersinvenousthromboembolismasurveyofrespiratoryphysicianshaematologistsandmedicaloncologistsandareviewoftheliterature AT dalyciara dilemmasinanticoagulationanduseofinferiorvenacavafiltersinvenousthromboembolismasurveyofrespiratoryphysicianshaematologistsandmedicaloncologistsandareviewoftheliterature AT sikotranisha dilemmasinanticoagulationanduseofinferiorvenacavafiltersinvenousthromboembolismasurveyofrespiratoryphysicianshaematologistsandmedicaloncologistsandareviewoftheliterature AT claytim dilemmasinanticoagulationanduseofinferiorvenacavafiltersinvenousthromboembolismasurveyofrespiratoryphysicianshaematologistsandmedicaloncologistsandareviewoftheliterature AT gabbayeli dilemmasinanticoagulationanduseofinferiorvenacavafiltersinvenousthromboembolismasurveyofrespiratoryphysicianshaematologistsandmedicaloncologistsandareviewoftheliterature |